1. Home
  2. FNKO vs CERS Comparison

FNKO vs CERS Comparison

Compare FNKO & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FNKO
  • CERS
  • Stock Information
  • Founded
  • FNKO 2017
  • CERS 1991
  • Country
  • FNKO United States
  • CERS United States
  • Employees
  • FNKO N/A
  • CERS N/A
  • Industry
  • FNKO Recreational Games/Products/Toys
  • CERS EDP Services
  • Sector
  • FNKO Consumer Discretionary
  • CERS Technology
  • Exchange
  • FNKO Nasdaq
  • CERS Nasdaq
  • Market Cap
  • FNKO 225.8M
  • CERS 265.7M
  • IPO Year
  • FNKO 2017
  • CERS 1997
  • Fundamental
  • Price
  • FNKO $2.78
  • CERS $1.24
  • Analyst Decision
  • FNKO Strong Buy
  • CERS Strong Buy
  • Analyst Count
  • FNKO 5
  • CERS 2
  • Target Price
  • FNKO $8.70
  • CERS $3.50
  • AVG Volume (30 Days)
  • FNKO 1.8M
  • CERS 1.2M
  • Earning Date
  • FNKO 08-07-2025
  • CERS 08-05-2025
  • Dividend Yield
  • FNKO N/A
  • CERS N/A
  • EPS Growth
  • FNKO N/A
  • CERS N/A
  • EPS
  • FNKO N/A
  • CERS N/A
  • Revenue
  • FNKO $970,702,000.00
  • CERS $192,510,000.00
  • Revenue This Year
  • FNKO N/A
  • CERS $24.95
  • Revenue Next Year
  • FNKO $9.96
  • CERS $11.88
  • P/E Ratio
  • FNKO N/A
  • CERS N/A
  • Revenue Growth
  • FNKO N/A
  • CERS 13.25
  • 52 Week Low
  • FNKO $2.22
  • CERS $1.12
  • 52 Week High
  • FNKO $14.65
  • CERS $2.39
  • Technical
  • Relative Strength Index (RSI)
  • FNKO 31.39
  • CERS 41.74
  • Support Level
  • FNKO $2.64
  • CERS $1.25
  • Resistance Level
  • FNKO $3.06
  • CERS $1.38
  • Average True Range (ATR)
  • FNKO 0.29
  • CERS 0.07
  • MACD
  • FNKO -0.09
  • CERS -0.00
  • Stochastic Oscillator
  • FNKO 27.45
  • CERS 15.79

About FNKO Funko Inc.

Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: